Short interest in BridgeBio Pharma Inc (NASDAQ:BBIO) increased during the last reporting period, rising from 24.16M to 24.39M. This put 13.9% of the company's publicly available shares short.

Based on the recent average volume of 2.54M shares traded per day, it would take 9.6 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.